Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novo Nordisk
Fierce Pharma
Novo, Lilly obesity meds 'highly cost-effective': ICER report
ICER has high confidence in the drugs' cost-effectiveness but also voiced concerns over the drugs' impact on healthcare budgets.
Eric Sagonowsky
Sep 9, 2025 10:30am
CVS hit with lawsuit over dropping Zepbound from formulary
Sep 5, 2025 4:58pm
Hims & Hers to offer generic semaglutide drugs in Canada
Jul 11, 2025 3:30pm
WeightWatchers inks deal with Novo Nordisk to sell Wegovy
Jun 26, 2025 3:30pm
Hims & Hers stock drops 30% after Novo Nordisk terminates deal
Jun 23, 2025 12:00pm
New Evernorth program to cap out-of-pocket costs for GLP-1s
May 21, 2025 4:30pm
